The Medicines and Healthcare products Regulatory Agency has approved the first-of-its-kind drug sotorasib for some people with non small cell lung cancer.
The spin out companies are engineering viruses to seek and destroy cancer cells and using bacteria to break down the physical defences of tumours.
The National Institute of Health and Care Excellence (NICE) has approved the use of pemigatinib in adults with a rare type of bile duct cancer that has continued to advance or spread after initial chemotherapy.
The three latest SMC decisions will provide new treatment options for some adults with non small cell lung cancer, multiple myeloma and a rare type of lymphoma.
A new targeted treatment has been recommended by the National Institute of Health and Care Excellence for some adults with ovarian cancer.
The Scottish Medicines Consortium (SMC) has approved a new chemotherapy-free treatment option for some adults with untreated chronic lymphocytic leukaemia.
The first chemotherapy-free drug combination for people with a rare type of bowel cancer has been approved for NHS use in England.
A new combination of targeted treatments will now be available for some adults with leukaemia on the NHS in England.
A new drug that has passed safety tests in adults is likely to be effective against the aggressive childhood cancer neuroblastoma.